Iontophoretic drug delivery across the nail

Expert Opinion on Drug Delivery

Volumn 9, Issue 1, 2012, Pages 91-103

  Delgado Charro, Maria Begoña ^a  

^a University of Bath   (United Kingdom)

Author keywords

Iontophoresis; Nail; Onychomycosis; Terbinafine; Topical

Indexed keywords

AMOROLFINE; CICLOPIROX; CICLOPIROXOLAMINE; FLUCONAZOLE; ITRACONAZOLE; TERBINAFINE; TIOCONAZOLE; TRIAMCINOLONE ACETONIDE;

DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG TRANSPORT; ELECTROOSMOSIS; FINGER NAIL; HUMAN; IN VIVO STUDY; IONTOPHORESIS; ONYCHOMYCOSIS; PH MEASUREMENT; REVIEW;

ANIMALS; ANTIFUNGAL AGENTS; DRUG DELIVERY SYSTEMS; ELECTRODES; ELECTROOSMOSIS; HUMANS; IONTOPHORESIS; NAIL DISEASES; NAILS; ONYCHOMYCOSIS; PSORIASIS;

EID: 84255171218     PISSN: 17425247     EISSN: 17447593     Source Type: Journal    
DOI: 10.1517/17425247.2012.642364     Document Type: Review

References (94)

1. Jiaravuthisan MM, Sasseville D, Vender RB, et al. Psoriasis of the nail: anatomy, pathology, clinical presentation, and a review of the literature on therapy. J Am Acad Dermatol 2007;57:1-27 (Pubitemid 46899261)
2. Thomas J, Jacobson GA, Narkowicz CK, et al. Toenail onychomycosis: an important global disease burden. J Clin Pharm Ther 2010;35:497-519
3. Edwards F, de Berker D. Nail psoriasis: clinical presentation and best practice recommendations. Drugs 2009;69:2351-61
4. Welsh O, Vera-Cabrera L, Welsh E. Onychomycosis. Clin Dermatol 2010;28:151-9
5. de Berker D. Management of psoriatic nail disease. Semin Cutan Med Surg 2009;28:39-43
6. de Berker D. Management of nail psoriasis. Clin Exp Dermatol 2000;25:357-62
7. Crawford F, Hart R, Bell-Syer S, et al. Topical treatments for fungal infections of the skin and nails of the foot. Cochrane Database Syst Rev 2000(1):CD001434
8. de Berker DA, Andre J, Baran R. Nail biology and nail science. Int J Cosmet Sci 2007;29:241-75 (Pubitemid 47101101)
9. Murdan S. Enhancing the nail permeability of topically applied drugs. Expert Opin Drug Del 2008;5:1267-82
10. Green DM, Brain KR, Walters KA. Nail Delivery. In: Rathbone MJ, Hadgraft J, Roberts MS, Lane ME, editors. Modified-release drug delivery technology. Volume 2 2nd edition. Informa Healthcare; New York: 2008. p. 383-93
11. Elkeeb R, AliKhan A, Elkeeb L, et al. Transungual drug delivery: current status. Int J Pharm Jan 2010;384:1-8
12. Leboulanger B, Guy RH, Delgado-Charro MB. Reverse iontophoresis for non-invasive transdermal monitoring. Phys Meas 2004;25:R35-50 (Pubitemid 38901997)
13. Burnette RR. Iontophoresis. In: Hadgraft J, Guy RH, editors. Transdermal drug delivery. Marcel Dekker; New York: 1989
14. Kalia YN, Naik A, Garrison J, Guy RH. Iontophoretic drug delivery. Adv Drug Deliver Rev 2004;56:619-58 (Pubitemid 38326937)
15. Delgado-Charro MB. Recent advances on transdermal iontophoretic drug delivery and non-invasive sampling. J Drug Deliv Sci Tec 2009;19:75-88
16. Delgado-Charro MB, Guy RH. Iontophoresis: Applications in drug delivery and non-invasive monitoring. In: Guy RH, Hadgraft J, editors, Transdermal drug delivery. 2nd edition. Marcel Dekker, New York; 2003
17. Eljarrat-Binstock E, Domb AJ. Iontophoresis: a non-invasive ocular drug delivery. J Control Release 2006;110:479-89 (Pubitemid 43163439)
18. Sage BH, Riviere JE. Model systems in iontophoresis-transport efficacy. Adv Drug Deliver Rev 1992;9:265-87
19. Phipps JB, Gyorr GG. Transdermal ion migration. Adv Drug Deliver Rev 1992;9:137-76
20. Pikal MJ. The role of electroosmotic flow in transdermal iontophoresis Adv Drug Deliver Rev. 1992;9:201-37
21. Ledger PW. Skin biological issues in electrically enhanced transdermal delivery. Adv Drug Deliver Rev 1992;9:289-307
22. Kasting GB, Keister JC. Application of electrodiffusion theory for a homogeneous membrane to iontophoretic transport through skin. J Control Release 1989;8:195-210 (Pubitemid 19098999)
23. Marro D, Kalia YN, Delgado-Charro MB, et al. Contributions of electromigration and electroosmosis to iontophoretic drug delivery. Pharm Res 2001;18:1701-8 (Pubitemid 34020425)
24. Mudry B, Carrupt PA, Guy RH, et al. Quantitative structure-permeation relationship for iontophoretic transport across the skin. J Control Release 2007;122:165-72 (Pubitemid 47361407)
25. Phipps JB, Padmanabhan RV, Lattin GA. Iontophoretic delivery of model inorganic and drug ions. J Pharm Sci 1989;78:365-9 (Pubitemid 20070543)
26. Mudry B, Guy RH, Delgado-Charro MB. Transport numbers in transdermal iontophoresis. Biophys J 2006;90:2822-30
27. Mudry B, Guy RH, Delgado-Charro MB. Electromigration of ions across the skin: determination and prediction of transport numbers. J Pharm Sci 2006;95:561-9
28. Gungor S, Delgado-Charro MB, Ruiz-Perez B, et al. Trans-scleral iontophoretic delivery of low molecular weight therapeutics. J Control Release 2010;147:225-31
29. Luzardo-Alvarez A, Rodriguez-Fernandez M, Blanco-Mendez J, et al. Iontophoretic permselectivity of mammalian skin: characterization of hairless mouse and porcine membrane models. Pharm Res 1998;15:984-7 (Pubitemid 28356911)
30. Marro D, Guy RH, Delgado-Charro MB. Characterization of the iontophoretic permselectivity properties of human and pig skin. J Control Release 2001;70:213-17 (Pubitemid 32144805)
31. Pikal MJ. Transport mechanisms in iontophoresis. I. A theoretical model for the effect of electroosmotic flow on flux enhancement in transdermal iontophoresis. Pharm Res 1990;7:118-26 (Pubitemid 20208062)
32. Burnette RR, Ongpipattanakul B. Characterization of the permselective properties of excised human skin during iontophoresis. J Pharm Sci 1987;76:765-73
33. Santi P, Guy RH. Reverse iontophoresis - parameters determining electro-osmotic flow. 2.Electrode chamber formulation. J Control Release 1996;42:29-36 (Pubitemid 26297873)
34. Santi P, Guy RH. Reverse iontophoresis - Parameters determining electroosmotic flow.1. pH and ionic strength. J Control Release 1996;38:159-65 (Pubitemid 26096660)
35. Guy RH, Delgado-Charro MB, Kalia YN. Iontophoretic transport across the skin. Skin Pharmacol Appl 2001;14(Suppl 1):35-40 (Pubitemid 34299162)
36. James MP, Graham RM, English J. Percutaneous iontophoresis of prednisolone-a pharmacokinetic study. Clin Exp Dermatol 1986;11:54-61 (Pubitemid 16201375)
37. Murthy SN, Waddell DC, Shivakumar HN, et al. Iontophoretic permselective property of human nail. J Dermatol Sci 2007;46:150-2 (Pubitemid 46467285)
38. Murthy SN, Wiskirchen DE, Bowers CP. Iontophoretic drug delivery across human nail. J Pharm Sci 2007;96:305-11 (Pubitemid 46363561)
39. Hao JS, Li SK. Transungual iontophoretic transport of polar neutral and positively charged model permeants: Effects of electrophoresis and electroosmosis. J Pharm Sci 2008;97:893-905 (Pubitemid 351293889)
40. Dutet J, Delgado-Charro MB. Electroosmotic transport of mannitol across human nail during constant current iontophoresis. J Pharm Pharmacol 2010;62:721-9
41. Dutet J, Delgado-Charro MB. Transungual iontophoresis of lithium and sodium: effect of pH and co-ion competition on cationic transport numbers. J Control Release 2010;144:168-74
42. Runne U, Orfanos CE. The human nail: structure, growth and pathological changes. Curr Probl Dermatol 1981;9:102-49
43. Hao J, Li SK. Mechanistic study of electroosmotic transport across hydrated nail plates: effects of pH and ionic strength. J Pharm Sci 2008;97:5186-97
44. Hao JS, Smith KA, Li SK. Chemical method to enhance transungual transport and iontophoresis efficiency. Int J Pharm 2008;357:61-9
45. Smith KA, Hao J, Li SK. Effects of ionic strength on passive and iontophoretic transport of cationic permeant across human nail. Pharm Res 2009;26:1446-55
46. Hao J, Smith KA, Li SK. Time-dependent electrical properties of human nail upon hydration in vivo. J Pharm Sci 2010;99:107-18
47. Hao J, Smith KA, Li SK. Iontophoretically enhanced ciclopirox delivery into and across human nail plate. J Pharm Sci 2009;98:3608-16
48. Nair AB, Vaka SR, Sammeta SM, et al. Trans-ungual iontophoretic delivery of terbinafine. J Pharm Sci 2009;98:1788-96
49. Nair AB, Kiran Vaka SR, Murthy SN. Transungual delivery of terbinafine by iontophoresis in onychomycotic nails. Drug Dev Ind Pharmacy 2011 published online 4 April 2011; doi:10.3109/03639045.2011.568946
50. Nair AB, Kim HD, Davis SP, et al. An ex vivo toe model used to assess applicators for the iontophoretic ungual delivery of terbinafine. Pharm Res 2009;26:2194-201
51. Amichai B, Mosckovitz R, Trau H, et al. Iontophoretic terbinafine HCL 1.0% delivery across porcine and human nails. Mycopathologia 2010;169:343-9
52. Ramaswamy C, Kim H, Fridam P, et al. Iontophoresis to enhance topical delivery of terbinafine to the nail. Skin Forum 8th Annual Meeting, 2007, p.24
53. Nair AB, Chakraborty B, Murthy SN. Effect of polyethylene glycols on the trans-ungual delivery of terbinafine. Curr Drug Delivery 2010;7:407-14
54. Nair AB, Sammeta SM, Kim HD, et al. Alteration of the diffusional barrier property of the nail leads to greater terbinafine drug loading and permeation. Int J Pharm 2009;375:22-7
55. Nair AB, Kim HD, Chakraborty B, et al. Ungual and trans-ungual iontophoretic delivery of terbinafine for the treatment of onychomycosis. J Pharm Sci 2009;98:4130-40
56. Murdan S, Hinsu D, Guimier M. A few aspects of transonychial water loss (TOWL): inter-individual, and intra-individual inter-finger, inter-hand and inter-day variabilities, and the influence of nail plate hydration, filing and varnish. Eur J Pharm Biopharm 2008;70:684-9
57. Smith KA, Hao J, Li SK. Influence of pH on transungual passive and iontophoretic transport. J Pharm Sci 2010;99:1955-67
58. Amichai B, Nitzan B, Mosckovitz R, et al. Iontophoretic delivery of terbinafine in onychomycosis: a preliminary study. Br J Dermatol 2010;162:46-50
59. Dutet J, Delgado-Charro MB. In vivo transungual iontophoresis: effect of DC current application on ionic transport and on transonychial water loss. J Control Release 2009;140:117-25
60. Gunt HB, Kasting GB. Effect of hydration on the permeation of ketoconazole through human nail plate in vitro. Eur J Pharm Sci 2007;32:254-60 (Pubitemid 350051888)
61. Nogueiras Nieto L, Gomez Amoza JL, Delgado Charro MB, et al. Hydration and N-acetyl-l-cysteine alter the microstructure of human nail and bovine hoof: Implications for drug delivery. J Control Release 2011;doi:10.1016/j.jconrel. 2011.08.021
62. Power Paper. Portfolio products. Therapeutic areas. Available from: www. powerpaper.com/?categoryId=43885 [Last accesed 5 July 2011]
63. Dutet J. Iontophoretic Drug Delivery to the Nail. University of Bath; Thesis: 2008
64. Guy RH, Kalia YN, Delgado-Charro MB, et al. Iontophoresis: electrorepulsion and electroosmosis. J Control Release 2000;64:129-32 (Pubitemid 30035313)
65. Bragulla HH, Homberger DG. Structure and functions of keratin proteins in simple, stratified, keratinized and cornified epithelia. J Anat 2009;214:516-59
66. Brett CMA, Oliveira Brett AM. Electrochemistry, Principles, Methods and Applications. Oxford University Press; Oxford: 1993
67. Turner NG, Guy RH. Visualization and quantitation of iontophoretic pathways using confocal microscopy. J Invest Dermatol 1998;3:136-42 (Pubitemid 29135209)
68. Turner NG, Guy RH. Iontophoretic transport pathways: dependence on penetrant physicochemical properties. J Pharm Sci 1997;86:1385-9
69. Bath BD, Scott ER, Phipps JB, et al. Scanning electrochemical microscopy of iontophoretic transport in hairless mouse skin. Analysis of the relative contributions of diffusion, migration, and electroosmosis to transport in hair follicles. J Pharm Sci 2000;89:1537-49
70. Scott ER, Phipps JB, White HS. Direct imaging of molecular transport through skin. J Invest Dermatol 1995;104:142-5
71. Orchard GE, Torres J, Sounthararajah R. Use of softening agents to improve the production of formalin-fixed, paraffin-embedded sections of nail tissue: an assessment. Brit J Biomed Sci 2008;65:68-70 (Pubitemid 351913977)
72. Frey BM, Walker C, Frey FJ, et al. Pharmacokinetics and pharmacodynamics of three different prednisolone prodrugs: effect on circulating lymphocyte subsets and function. J Immunol 1984;133:2479-87 (Pubitemid 15204772)
73. Frey FJ, Ruegsegger MK, Frey BM. The dose-dependent systemic availability of prednisone: one reason for the reduced biological effect of alternate-day prednisone. Brit J Clin Pharmacol 1986;21:183-9 (Pubitemid 17189978)
74. Sakata S, Howard A. Pseudomonas chloronychia in a patient with nail psoriasis. Med J Aust 2007;186:424 (Pubitemid 46691866)
75. Thysman S, Van Neste D, Preat V. Noninvasive investigation of human skin after in vivo iontophoresis. Skin Pharmacol 1995;8:229-36
76. Curdy C, Kalia YN, Falson-Rieg F, et al. Recovery of human skin impedance in vivo after iontophoresis: effect of metal ions. AAPS PharmSci 2000;2:E23
77. Curdy C, Kalia YN, Guy RH. Post-iontophoresis recovery of human skin impedance in vivo. Eur J Pharm Biopharm 2002;53:15-21 (Pubitemid 34036993)
78. Curdy C, Kalia YN, Guy RH. Non-invasive assessment of the effects of iontophoresis on human skin in-vivo. J Pharm Pharmacol 2001;53:769-77 (Pubitemid 32529719)
79. Benzeval I, Bowen CR, Guy RH, et al. Evaluation of the effect of iontophoresis on human nail in vitro by impedance and infrared spectroscopies. Skin Forum 11th Annual Meeting 2010, p.3
80. Barsness M, Davis SP, Etheredge R. Studies in drug transport vs. current in iontophoretic onychomycosis treatment. Conf Proc IEEE Eng Med Biol Soc 2009;289-94
81. Leboulanger B, Aubry JM, Bondolfi G, et al. Lithium monitoring by reverse iontophoresis in vivo. Clin Chem 2004;50:2091-100 (Pubitemid 39425847)
82. Sieg A, Guy RH, Delgado-Charro MB. Noninvasive glucose monitoring by reverse iontophoresis in vivo: application of the internal standard concept. Clin Chem 2004;50:1383-90 (Pubitemid 38970646)
83. Hendriksen BA, Felix MV, Bolger MB. The composite solubility versus pH profile and its role in intestinal absorption prediction. AAPS PharmSci 2003;5:E4
84. Uzqueda M, Martin C, Zornoza A, et al. Physicochemical characterization of terbinafine-cyclodextrin complexes in solution and in the solid state. J Inc Phenom Macrocycl Chem 2010;66:393-402
85. Oon HH, Tan HH. Iontophoretic terbinafine delivery in onychomycosis: questionable nail growth. Br J Dermatol 2010;162:699-700
86. Neubert RHH, Gensbugel C, Jackel A, et al. Different physichochemical properties of antmycotic agents are relevant for penetration into and through human nails. Pharmazie 2006;61:604-7 (Pubitemid 44098027)
87. Hui X, Baker SJ, Wester RC, et al. In vitro penetration of a novel oxaborole antifungal (AN2690) into the human nail plate. J Pharm Sci 2007;96:2622-31 (Pubitemid 47597813)
88. Jaruratanasirikul S, Sriwiriyajan S. Effect of omeprazole on the pharmacokinetics of itraconazole. Eur J Clin Pharmacol 1998;54:159-61 (Pubitemid 28204270)
89. Courtney R, Wexler D, Radwanski E, et al. Effect of food on the relative bioavailability of two oral formulations of posaconazole in healthy adults. Br J Clin Pharmacol 2003;57:218-22
90. Ruela Correa JC, Nunes Salgado HR. Review of fluconazole properties and analytical methods for its determination. CRC CR Rev Anal Chem 2011;41:124:32
91. Ferguson PD, Goodall DM, Loran JS. Systematic approach to the treatment of enantiomeric separations in capillary electrophoresis and liquid chromatography. III A binding constant-retention factor relationship and effects of acetonitrile on the chiral separation of tioconazole. J Chromatogr A 1996;745:25-35 (Pubitemid 26319862)
92. Howard JR, Gould PL. Drug release from thermosetting fatty vehicles filled into hard gelatin capsules. Drug Dev Ind Pharm 1987;13:1031-45 (Pubitemid 17100412)
93. Thakur A, Kadam RS, Kompella UB. Influence of drug solubility and lipophilicity on transscleral retinal delivery of six corticosteroids. Drug Metab Dispos 2011;39:771-81
94. Unghphaiboon S, Nittayananta W, Vuddhakul V, et al. Formulation and efficacy of triamcinolone acetonide mouthwash for treating oral lichen planus. Am J Health-Syst Pharm 2005;62:485-91 (Pubitemid 40332258)